Milton J. Wallace, Director at CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX), bought 125,000 shares at $0.80 ($100K) on 2012-05-24, disclosed to the SEC on 2012-05-29.
Open-market purchase of $100k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| IPII | BUY | 2011-08-18 | $1K | — | Filing → |
| IPII | BUY | 2011-06-02 | $340 | — | Filing → |
| IPII | BUY | 2011-05-20 | $2K | — | Filing → |